Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023
| dc.authorid | 0000-0002-6398-281X | |
| dc.authorid | 0000-0003-0926-3029 | |
| dc.contributor.author | Yılmaz, Mehmet Kürşat | |
| dc.contributor.author | Abbaszadeh, Ahmad | |
| dc.contributor.author | Tarabichi, Saad | |
| dc.contributor.author | Azboy, İbrahim | |
| dc.contributor.author | Parvizi, Javad | |
| dc.date.accessioned | 2023-07-10T09:04:59Z | |
| dc.date.available | 2023-07-10T09:04:59Z | |
| dc.date.issued | 2023 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Ortopedi ve Travmatoloji Ana Bilim Dalı | |
| dc.description.abstract | Periprosthetic joint infection (PJI) is a rare yet devastating complication following total joint arthroplasty (TJA). Early and accurate diagnosis of PJI is paramount in order to maximize the chances of successful treatment. However, we are yet to identify a single "gold standard" test for the diagnosis of PJI. As a result, the diagnosis of PJI is often challenging. Currently, the 2018 ICM definition of PJI is the only validated diagnostic criteria available. This article will review the importance of serum and synovial biomarkers in the diagnosis of PJI. In addition, it will provide a brief overview of the emerging modalities for the identification of infections in this setting. | |
| dc.identifier.citation | Yılmaz, M. K., Abbaszadeh, A., Tarabichi, S., Azboy, İ. ve Parvizi, J. (2023). Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023. Antibiotics-Basel, 12(6). https://dx.doi.org/10.3390/antibiotics12061054 | |
| dc.identifier.doi | 10.3390/antibiotics12061054 | |
| dc.identifier.issn | 2079-6382 | |
| dc.identifier.issue | 6 | |
| dc.identifier.pmid | 37370373 | |
| dc.identifier.scopus | 2-s2.0-85163757312 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://dx.doi.org/10.3390/antibiotics12061054 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/11174 | |
| dc.identifier.volume | 12 | |
| dc.identifier.wos | 001013826700001 | en_US |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | Yılmaz, Mehmet Kürşat | |
| dc.institutionauthor | Azboy, İbrahim | |
| dc.language.iso | en | |
| dc.publisher | MDPI | |
| dc.relation.ispartof | Antibiotics-Basel | en_US |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | Attribution 4.0 International | * |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Periprosthetic Joint Infection | |
| dc.subject | Serum | |
| dc.subject | Synovial Fluid | |
| dc.subject | Marker | |
| dc.title | Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023 | |
| dc.type | Review Article |
